by Victoria Woods, on behalf of the Think Brain Health Steering Committee
The EAN Scientific Panel on Dementia and cognitive disorders is delighted to announce its decision to endorse an evidence-based international consensus report, Time matters: a call to prioritize brain health, which is available here: https://www.thinkbrainhealth.org/
This report has been developed by a diverse group of experts in Alzheimer’s disease and Parkinson’s disease. It aims to help healthcare professionals, policymakers, researchers and the general public to act early to:
- promote public understanding that preventing brain disease is possible and that ‘what’s good for the heart is good for the brain’
- prepare healthcare professionals to manage people with or at risk of neurodegenerative brain disease
- prioritize research and build infrastructure to enable prevention, early detection and management of neurodegenerative brain disease.
The report presents an expert, evidence-based position for policy recommendations that encourage individuals to participate actively in prioritizing their own brain health. It also challenges policymakers, researchers, funding bodies and healthcare professionals to collaborate in planning for future healthcare structures.
Think Brain Health – a policy, clinical and research challenge
24‒25 November 2020
Additionally, we invite you to register for free for the first ever Think Brain Healthconference to hear directly from a range of experts on the importance of good brain health for all.
Healthcare professionals, public health professionals, researchers, policymakers and patient advocates with an interest in good brain health and prevention of brain disease are invited to our free, virtual conference: Think Brain Health – a policy, clinical and research challenge. Delegates may choose to attend one or both 90-minute sessions.
- Health promotion and clinical risk management, 24 November. Chaired by Dr Alastair Noyce, Queen Mary University of London
- Research needs in brain health, 25 November. Chaired by Professor Philip Scheltens, Alzheimer Center Amsterdam
